BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 38616211)

  • 1. What is new in acute myeloid leukemia classification?
    Park HS
    Blood Res; 2024 Apr; 59(1):15. PubMed ID: 38616211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Updates in molecular genetics of acute myeloid leukemia.
    Kurzer JH; Weinberg OK
    Semin Diagn Pathol; 2023 May; 40(3):140-151. PubMed ID: 37059636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and genomic characterization of patients diagnosed with the provisional entity acute myeloid leukemia with BCR-ABL1, a Swedish population-based study.
    Orsmark-Pietras C; Landberg N; Lorenz F; Uggla B; Höglund M; Lehmann S; Derolf Å; Deneberg S; Antunovic P; Cammenga J; Möllgård L; Wennström L; Lilljebjörn H; Rissler M; Fioretos T; Lazarevic VL
    Genes Chromosomes Cancer; 2021 Jun; 60(6):426-433. PubMed ID: 33433047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparative analysis of the clinical and genetic profiles of blast phase BCR::ABL1-negative myeloproliferative neoplasm and acute myeloid leukemia, myelodysplasia-related.
    Chen D; Geyer J; Bagg A; Hasserjian R; Weinberg OK
    Int J Lab Hematol; 2024 Apr; ():. PubMed ID: 38665121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Classification of acute myeloid leukemia by the revised fourth edition World Health Organization criteria: a retrospective single-institution study with appraisal of the new entities of acute myeloid leukemia with gene mutations in NPM1 and biallelic CEBPA.
    Kansal R
    Hum Pathol; 2019 Aug; 90():80-96. PubMed ID: 31077683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implications of the 5
    Lee C; Kim HN; Kwon JA; Yoon SY; Jeon MJ; Yu ES; Kim DS; Choi CW; Yoon J
    Ann Lab Med; 2023 Sep; 43(5):503-507. PubMed ID: 37080752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A real-world analysis of clinical outcomes in AML with myelodysplasia-related changes: a comparison of ICC and WHO-HAEM5 criteria.
    Zhou Q; Zhao D; Zarif M; Davidson MB; Minden MD; Tierens A; Yeung YWT; Wei C; Chang H
    Blood Adv; 2024 Apr; 8(7):1760-1771. PubMed ID: 38286462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The International Consensus Classification of myelodysplastic syndromes and related entities.
    Hasserjian RP; Orazi A; Orfao A; Rozman M; Wang SA
    Virchows Arch; 2023 Jan; 482(1):39-51. PubMed ID: 36287260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AML classification in the year 2023: How to avoid a Babylonian confusion of languages.
    Huber S; Baer C; Hutter S; Dicker F; Meggendorfer M; Pohlkamp C; Kern W; Haferlach T; Haferlach C; Hoermann G
    Leukemia; 2023 Jul; 37(7):1413-1420. PubMed ID: 37120689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AML with CEBPA mutations: A comparison of ICC and WHO-HAEM5 criteria in patients with 20% or more blasts.
    Zhao D; Zhou Q; Zarif M; Eladl E; Wei C; Atenafu EG; Schuh A; Tierens A; Yeung YWT; Minden MD; Chang H
    Leuk Res; 2023 Nov; 134():107376. PubMed ID: 37690321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes of acute myeloid leukemia with myelodysplasia related changes depend on diagnostic criteria and therapy.
    Montalban-Bravo G; Kanagal-Shamanna R; Class CA; Sasaki K; Ravandi F; Cortes JE; Daver N; Takahashi K; Short NJ; DiNardo CD; Jabbour E; Borthakur G; Naqvi K; Issa GC; Konopleva M; Khoury JD; Routbort M; Pierce S; Do KA; Bueso-Ramos C; Patel K; Kantarjian H; Garcia-Manero G; Kadia TM
    Am J Hematol; 2020 Jun; 95(6):612-622. PubMed ID: 32112433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The International Consensus Classification of acute myeloid leukemia.
    Weinberg OK; Porwit A; Orazi A; Hasserjian RP; Foucar K; Duncavage EJ; Arber DA
    Virchows Arch; 2023 Jan; 482(1):27-37. PubMed ID: 36264379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What's in a Name? The Many Classifications of Acute Myeloid Leukemia with Dysplasia.
    Taylor NC; Conant JL; Gardner JA
    J Assoc Genet Technol; 2023; 49(2):93-99. PubMed ID: 37269294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advances towards genome-based acute myeloid leukemia classification: A comparative analysis of WHO-HAEM4R, WHO-HAEM5, and International Consensus Classification.
    Chen X; Yuan L; Zhang Y; Wang F; Ma X; Fang J; Cao P; Liu Y; Liu Z; Liu M; Chen J; Zhou X; Liu M; Jin D; Wang T; Lu P; Liu H
    Am J Hematol; 2024 May; 99(5):824-835. PubMed ID: 38321864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute Myeloid Leukemia With Myelodysplasia-Related Changes: A New Definition.
    Weinberg OK; Arber DA
    Surg Pathol Clin; 2010 Dec; 3(4):1153-64. PubMed ID: 26839302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic Precision or Pitfalls: How to Apply the New Acute Myeloid Leukemia Classification Systems?
    Carlson KS; Cunningham A; Stahl M; Winer E; Michaelis LC
    Acta Haematol; 2024; 147(2):122-132. PubMed ID: 38071966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reclassification of Acute Myeloid Leukemia According to the 2016 WHO Classification.
    Jung J; Cho BS; Kim HJ; Han E; Jang W; Han K; Lee JW; Chung NG; Cho B; Kim M; Kim Y
    Ann Lab Med; 2019 May; 39(3):311-316. PubMed ID: 30623623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of the International Consensus Classification and World Health Organization 5th edition classification to a series of myeloid neoplasms.
    Chopra S; Bailey NG
    Am J Clin Pathol; 2023 Dec; 160(6):566-570. PubMed ID: 37587830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ASXL1 mutation as a surrogate marker in acute myeloid leukemia with myelodysplasia-related changes and normal karyotype.
    Prats-Martín C; Burillo-Sanz S; Morales-Camacho RM; Pérez-López O; Suito M; Vargas MT; Caballero-Velázquez T; Carrillo-Cruz E; González J; Bernal R; Pérez-Simón JA
    Cancer Med; 2020 Jun; 9(11):3637-3646. PubMed ID: 32216059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The new diagnostic criteria for myelodysplasia-related acute myeloid leukemia is useful for predicting clinical outcome: comparison of the 4th and 5th World Health Organization classifications.
    Park HS; Kim HK; Kim HS; Yang Y; Han HS; Lee KH; Son BR; Kwon J
    Ann Hematol; 2022 Dec; 101(12):2645-2654. PubMed ID: 36220882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.